Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00117663 · ClinicalTrials.gov registry record · NA
Radiologic Evaluation and Breast Density (READ)
A NA study, sponsored by Kaiser Permanente.
- Completed
- Registry status
- NA
- Development phase
- 1,704
- Enrollment target
NCT00117663 is a NA study that has completed, run by Kaiser Permanente. The registered enrollment target is 1,704 participants.
The verdict
NCT00117663, a NA study, has completed, sponsored by Kaiser Permanente.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,704 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether cessation of hormone replacement therapy for one or two months before a screening mammogram will improve its performance by decreasing breast density.
Interventions
- OTHER temporary discontinuation of hormone therapy for 1 month
- OTHER temporary discontinuation of hormone therapy for 2 months
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,704 participants |
| Start Date | 2004-11 |
| Est. Completion | 2007-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00117663
The ClinicalTrials.gov registry entry for NCT00117663 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,704 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kaiser Permanente, which has 294 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which temporary discontinuation of hormone therapy for 1 month is the first listed.
NCT00117663 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00117663 about?
NCT00117663 is a clinical study titled "Radiologic Evaluation and Breast Density (READ)". The purpose of this study is to determine whether cessation of hormone replacement therapy for one or two months before a screening mammogram will improve its performance by decreasing breast density.
What is the current status of trial NCT00117663?
This trial is currently completed. It is a NA study. The enrollment target is 1,704 participants. The study started on 2004-11. Estimated completion is 2007-11.
What interventions are being tested in trial NCT00117663?
The interventions under investigation include: temporary discontinuation of hormone therapy for 1 month (OTHER), temporary discontinuation of hormone therapy for 2 months (OTHER).
Who is sponsoring clinical trial NCT00117663?
This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.